Skip Navigation

Cardiovascular Research 2000 45(2):351-359; doi:10.1016/S0008-6363(99)00371-5
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Inserte, J.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inserte, J.
Right arrow Articles by Soler-Soler, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Urodilatin limits acute reperfusion injury in the isolated rat heart

Javier Inserte, David Garcia-Dorado*, Luis Agulló, Amaya Paniagua and Jordi Soler-Soler

Servicio de Cardiologìa, Hospital General Universitari Vall d’Hebron, Passeig Vall d’Hebron, 119–129, 08035 Barcelona, Spain

* Corresponding author. +34-93-4894038; fax: +34-93-4894032 dgdorado{at}hg.vhebron.es

Objectives: Hypercontracture is an important mechanism of myocyte death during reperfusion. cGMP modulates the sensitivity of contractile myofilaments to Ca2+, and increasing cGMP concentration during the last minutes of anoxia prevents reoxygenation-induced hypercontracture in isolated cardiomyocytes. The purpose of this study was to determine whether stimulation of particulate guanylyl cyclase with the natriuretic peptide urodilatin, given at the time of reperfusion, reduces myocardial necrosis in the rat heart submitted to transient ischemia. Methods: Isolated rat hearts (n=38) were submitted to either 40 or 60 min of no-flow ischemia and 2 h of reperfusion, and were allocated to receive or not receive 0.05 µM urodilatin during the first 15 min of reperfusion or non-reperfusion treatment. Results: A marked reduction in myocardial cGMP concentration was observed in control hearts during reperfusion after 40 or 60 min of ischemia. Urodilatin significantly attenuated cGMP depletion during initial reperfusion, markedly improved contractile recovery after 40 min of ischemia (P<0.0309), and reduced reperfusion-induced increase in left ventricular end-diastolic pressure (P=0.0139), LDH release (P=0.0263), and contraction band necrosis (P=0.0179) after 60 min of ischemia. The beneficial effect of urodilatin was reproduced by the membrane permeable cGMP analog 8-Bromo-cGMP. Conclusions: These results indicate that reduced cGMP concentration may impair myocyte survival during reperfusion. Stimulation of particulate guanylyl cyclase may appear as a new strategy to prevent immediate lethal reperfusion injury.

KEYWORDS Ischemia; Natriuretic peptide; Necrosis; Reperfusion; Second messengers


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Inserte, J. A. Barrabes, V. Hernando, and D. Garcia-Dorado
Orphan targets for reperfusion injury
Cardiovasc Res, July 15, 2009; 83(2): 169 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Kuno, N. V. Solenkova, V. Solodushko, T. Dost, Y. Liu, X.-M. Yang, M. V. Cohen, and J. M. Downey
Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1288 - H1295.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Hamid, H. S. Bower, and G. F. Baxter
Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2598 - H2606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Moldobaeva, L. E. Welsh-Servinsky, L. A. Shimoda, R. S. Stephens, A. D. Verin, R. M. Tuder, and D. B. Pearse
Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L919 - L930.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero
The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion
Cardiovasc Res, May 1, 2006; 70(2): 274 - 285.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Abdallah, A. Gkatzoflia, H. Pieper, E. Zoga, S. Walther, S. Kasseckert, M. Schafer, K.D. Schluter, H.M. Piper, and C. Schafer
Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury
Cardiovasc Res, April 1, 2005; 66(1): 123 - 131.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Sangawa, K. Nakanishi, K. Ishino, M. Inoue, M. Kawada, and S. Sano
Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart
Ann. Thorac. Surg., January 1, 2004; 77(1): 233 - 237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler
Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2170 - H2176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, N. Escalona, J. Inserte, M. Ruiz-Meana, J. A. Barrabes, M. Mirabet, P. Pina, and J. Soler-Soler
Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H917 - H925.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, M. Ruiz-Meana, F. Padilla, A. Rodriguez-Sinovas, and M. Mirabet
Gap junction-mediated intercellular communication in ischemic preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 456 - 465.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Padilla, D. Garcia-Dorado, L. Agullo, J. A Barrabes, J. Inserte, N. Escalona, M. Meyer, M. Mirabet, P. Pina, and J. Soler-Soler
Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs
Cardiovasc Res, August 15, 2001; 51(3): 592 - 600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Ruiz-Meana, D. Garcia-Dorado, S. Lane, P. Pina, J. Inserte, M. Mirabet, and J. Soler-Soler
Persistence of gap junction communication during myocardial ischemia
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2563 - H2571.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Padilla, D. Garcia-Dorado, L. Agullo, J. Inserte, A. Paniagua, S. Mirabet, J. A. Barrabes, M. Ruiz-Meana, and J. Soler-Soler
L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig
Cardiovasc Res, June 1, 2000; 46(3): 412 - 420.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.